ARTICLE | Management Tracks
Third Rock’s Finer becomes Septerna’s full-time CEO
Plus Thieroff-Ekerdt to head clinical development at Cambrian and an update from Curemark
September 23, 2022 12:30 AM UTC
Jeffrey Finer became full-time CEO of Septerna Inc., a Third Rock-backed GPCR small molecules company. Finer, who is also a venture partner at Third Rock, co-founded Septerna in 2019 and transitions from his role as interim CEO.
Longevity biotech Cambrian Biopharma Inc. hired Ruth Thieroff-Ekerdt as EVP of clinical development. Thieroff-Ekerdt was scientific adviser at Organon & Co. (NYSE:OGN), and CMO at Sojournix Inc., Aptalis Pharma Inc., Strongbridge Biopharma plc and Kaleido Biosciences Inc. (NASDAQ:KLDO)...